On April 26, Ge Longhui Pharmaceutical (300149.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 235 million yuan, a year-on-year decrease of 12.68%; net profit attributable to shareholders of listed companies - 254.606 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - RMB 28.00.94 million; basic earnings per share - 0.0509 yuan.
睿智医药(300149.SZ)：一季度净亏损2546.06万元
Wisdom Pharmaceutical (300149.SZ): Net loss of 254.606 million yuan in the first quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.